USANA Health Sciences Inc. (USNA) Upgraded to Strong-Buy by Zacks Investment Research


The brokerage presently has a $158.00 price target on the stock. Zacks Investment Research's price target suggests a potential upside of 15.06% from the company's previous close.



from Biotech News